Lupin launches generic Nystatin and Triamcinolone Acetonide Cream

30 Nov 2018 Evaluate

Lupin has launched Nystatin and Triamcinolone Acetonide Cream USP 100,000 units/gm; 0.1%, having received an approval from the United States Food and Drug Administration (USFDA) earlier. Nystatin and Triamcinolone Acetonide Cream had annual sales of $54.3 million in the US as per IQVIA MAT September 2018.

The company’s Nystatin and Triamcinolone Acetonide Cream USP 100,000 units/gm; 0.1% is the generic equivalent of Taro Pharmaceuticals’ Nystatin and Triamcinolone Acetonide Cream. It is indicated for the treatment of cutaneous candidiasis.

Lupin is an innovation led transnational pharmaceutical company developing and delivering a wide range of branded & generic formulations, biotechnology products and APIs globally.


Lupin Share Price

2097.65 5.70 (0.27%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×